Amiodarone and Dofetilide: Interaction Details

Brand names
Amiodarone
CordaronePaceroneNexterone
Dofetilide
Tikosyn
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Amiodarone

Brand names
  • Cordarone
  • Pacerone
  • Nexterone

What Happens When You Take Amiodarone With Dofetilide

What can happen when they are taken together (rated Major)

An increased risk of (, , cardiac arrest)

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Using two Class III antiarrhythmic agents together can produce effects on the , and this combination is not recommended.2 QTc prolongation and/or torsades de pointes have been reported with every Class III antiarrhythmic agent, among them acecainide,3 amiodarone,1 azimilide,4 ibutilide,5 sematilide,6 dofetilide,7 and tedisamil.8

Class III antiarrhythmics should not be given at the same time as ibutilide, nor within four hours after an ibutilide infusion ends.9 Before dofetilide is started, other Class III antiarrhythmic agents should be held for a minimum of 3 half-lives, and before ibutilide is given they should be held for at least 5 half-lives and also for 4 hours after administration. Dofetilide should be discontinued at least 2 days before starting any interacting drug.2

The Amiodarone and Dofetilide Interaction, Explained

Amiodarone and dofetilide both treat abnormal heart rhythms, and both can lengthen the heart's electrical recovery time (the ). Taken together, that effect can add up. This raises the chance of a dangerous rhythm problem called , which can lead to cardiac arrest. It can happen quickly. The documented risk is based on how these drugs work rather than on large studies of this exact pair, but it is still taken seriously, and combining two drugs of this type is not recommended.

Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor about your heart rhythm plan. Your care team can choose the safest approach and monitor your heart closely if needed.

() between two Class III antiarrhythmics: amiodarone (multichannel blocker, IKr ) and dofetilide (selective IKr blocker). Risk: QTc prolongation, , cardiac arrest. Onset rapid. Evidence is theoretical/class-based, though TdP has been reported with all Class III agents. Severity: major.

  • is not recommended.
  • Withhold other Class III agents for at least 3 half-lives before starting dofetilide (amiodarone's is very long, so washout is prolonged).
  • Dofetilide should be stopped at least 2 days before starting an interacting drug.
  • If a transition is unavoidable, individualize and monitor , , electrolytes (K, Mg), and function.

See the 9 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Amiodarone and Dofetilide Interact

The likely mechanism

effect on

In short: Amiodarone and dofetilide both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Amiodarone and Dofetilide Interaction

Because this combination is not recommended, your care team will usually avoid using both together and plan any switch carefully.

  • Your team may need to stop one medicine for a set period before starting the other. The documented guidance is at least 3 half-lives after other Class III drugs before dofetilide starts, and dofetilide stopped at least 2 days before an interacting drug begins.
  • Your team may monitor you more closely during any transition, and doses may need to be adjusted and individualized.

Keep taking your medicines as prescribed until your doctor tells you otherwise. Tell your pharmacist and prescriber about every heart medicine you take, and seek urgent care for fainting, a racing or pounding heartbeat, or severe dizziness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Amiodarone or Dofetilide need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Potentially significant drug interactions of class III antiarrhythmic drugs

    Every class III antiarrhythmic agent has the potential to lengthen the , and using more than one class III antiarrhythmic agent at the same time is not recommended. Class III antiarrhythmic agents should be held for 3 half-lives before dofetilide is started, and for 5 half-lives before and 4 hours after ibutilide is given.

    Dofetilide should be discontinued for a minimum of 2 days before any interacting drug is begun. When cannot be avoided, careful dosing and telemetric monitoring are advised.2

Amiodarone and Dofetilide: Common Questions

How serious is the Amiodarone and Dofetilide interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Amiodarone and Dofetilide interaction managed?

Because this combination is not recommended, your care team will usually avoid using both together and plan any switch carefully. Your team may need to stop one medicine for a set period before starting the other. The documented guidance is at least 3 half-lives after other Class III drugs before dofetilide starts, and dofetilide stopped at least 2 days before an interacting drug begins. Your team… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Amiodarone and Dofetilide Interaction

Ask in your own words about taking Amiodarone and Dofetilide together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (9)

  1. Faggiano P, Gardini A, D'Aloia A, et al: Torsade de pointes occurring early during oral amiodarone treatment. Int J Cardiol 1996; 55(2):205-208. PubMed
  2. Yamreudeewong W, DeBisschop M, Martin LG, et al: Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Safety 2003; 26(6):421-438. PubMed
  3. Chow MJ, Piergies AA, Bowsher DJ, et al: Torsade de pointes induced by N-acetylprocainamide. J Am Coll Cardiol 1984; 4:621-624. PubMed
  4. Corey AE, Agnew JR, Valentine SN, et al: Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation. J Clin Pharmacol 1999; 39(12):1272-1276. DOI
  5. Rodriguez I, Kilborn MJ, Liu XK, et al: Drug-induced QT prolongation in women during the menstrual cycle. JAMA 2001; 285(10):1322-1326. PubMed
  6. Singh BN: The coming of age of the class III antiarrhythmic principle: retrospective and future trends. Am J Cardiol 1996; 78(suppl):17-27. PubMed
  7. Allen MJ, Oliver SD, Newgreen MW, et al: Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval. Br J Clin Pharmacol 2002; 53:59-65.
  8. Bargheer K, Bode F, Klein HU, et al: Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent. Eur Heart J 1994; 15:1409-1414. PubMed
  9. Product Information: Corvert(R), ibutilide fumarate injection. Upjohn Company, Kalamazoo, MI, 1998. DailyMed
Was this write-up helpful?

Other Serious Interactions of Amiodarone and Dofetilide

Also serious with Amiodarone

Also serious with Dofetilide

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Amiodarone

With Dofetilide

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.